How important is cervical cancer screening in women during pregnancy?

Share This Post

1. The importance of cervical cancer screening in women during pregnancy

Juvenile laryngeal papilloma is more common in children and adolescents, mainly pregnant women with low-risk HPV infection in the reproductive tract during pregnancy, which is caused by mother-to-child transmission to infants during delivery through the birth canal, mainly HPV infections type 6 and 11. Children with juvenile laryngeal papilloma may have no clinical symptoms in the early stage. As the laryngeal papilloma increases, respiratory symptoms appear. If the lesion is extensive, it may cause severe breathing difficulties and death. Screening of cervical cancer in pregnant women to prevent HPV infection can effectively prevent the virus from being transmitted to babies through childbirth. The birth of a healthy baby will undoubtedly contribute to individuals, families and society.

2. Methods of screening for cervical cancer in women during pregnancy. Routine high-risk HPV typing and liquid-based cytology tests are performed on women before pregnancy.

If the test result is positive, colposcopy is recommended. Colposcopy found a suspicious lesion and gave a cervical biopsy. If cervical cancer or precancerous lesions are found, wait for the cervical lesions to heal before considering fertility.

3. HPV infection in pregnant women. Pregnant women detect low-risk HPV infections in the reproductive tract before and after pregnancy, especially HPV types 6 and 11. The pregnant woman should be delivered by caesarean section to minimize the incidence of juvenile laryngeal papilloma.

Cervical cancer screening for pregnant women or women of appropriate age is particularly important, because this group of people bears the happiness of two or even three generations. Since the birth of a healthy baby, since human intervention can be used for disease prevention, medicine has developed so progressively. Medical technology can benefit people and prevent diseases before they happen. So, dear female compatriots, what are you waiting for? Hurry up and join the cervical cancer screening team.

Subscribe To Our Newsletter

Get updates and never miss a blog from Cancerfax

More To Explore

CAR T Cell therapy for AIDS related B Cell malignancies
Aids cancer

CAR T Cell therapy for AIDS related B-Cell malignancies

CAR T cell therapy for HIV-related B cell malignancies involves genetically modifying a patient’s T cells to express chimeric antigen receptors (CARs) targeting CD19 on B cells. This treatment holds promise in eradicating malignant B cells but must carefully manage immunosuppression in HIV-positive individuals.

Cancer statistics in India 2024
Cancer

Cancer statistics in India 2024: Incidence, estimates and projections

In 2024, cancer will remain a significant health challenge in India. The country sees over 1.5 million new cases a year. Breast and oral cancers are most prevalent among women and men, respectively. Sadly, many cases are diagnosed late, impacting survival rates. Improved awareness and access to healthcare are crucial. By 2030, cancer incidence is expected to surpass 1.7 million cases annually. Efforts to enhance prevention, early detection, and treatment access are crucial to mitigate this growing burden. Check our cancer statistics in India for 2024 and future projections.

Need help? Our team is ready to assist you.

We wish a speedy recovery of your dear and near one.

Start chat
Need help with cancer treatment?
Scan the code
Hello,
Welcome to CancerFax !

CancerFax is the most trusted international patient facilitator working with top cancer hospital's in the world like MD Anderson, Dana Farber, Asan, NCC Japan, Sheba, Beijing Cancer Institute and Apollo to bring you best of therapies and drugs.

Let us know what services would you like to avail?

1) Cancer treatment in the USA, Japan, Israel, India, Korea or Singapore?
2) CAR T-Cell therapy treatment
3) Cancer vaccine
4) Online video consultation
5) Proton therapy